News and Trends 26 Sep 2016 A Colony from a single-cell? All possible with Takara Bio …of cells at the beginning of the culture. What is interesting here is the right of the diagram where the cells were seeded with one or less cells/well. First, this… September 26, 2016 - 3 minutesmins - By Jerome Topsent Share WhatsApp Twitter Linkedin Email
In Depth 19 Mar 2025 Breast cancer treatments heat up: Five therapies poised to transform patient outcomes …the past decade. There is a direct link between this statistic and the wide array of new breast cancer treatments that have become available on the market. In fact, when… March 19, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 May 2024 Eight monoclonal antibody biotechs making strides in the clinic …let us take a look at eight biotech companies dedicated to advancing their monoclonal antibodies through the clinic, and that have made the news in recent times. Table of contents… May 2, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 27 Mar 2024 Are new treatments for multiple sclerosis on the horizon? …yet to take on the market that addresses the root cause and fully heals patients. Nevertheless, ongoing drug trials aim to not only expand therapeutic options but also provide treatment… March 27, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 9 May 2023 Researchers overcome stem cell delivery issues …to cause them to change into a particular type of cell. Once the cells have differentiated into the target cell type, we put them into the area of the body… May 9, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 19 Jul 2022 Cells for Cells treats first patient with exosome-produced therapy for osteoarthritis …as disease-modifying agents,” Khoury said. The XO-101 product was first in the race to the clinic and could be among the first exosome therapies approved by the FDA. Following this,… July 19, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 17 Dec 2024 Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic …immune cell that can trigger the immune system to recognize and fight cancer. These dendritic cells are then returned back to the patient, making it a personalized vaccine. Building on… December 17, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 20 Dec 2022 Ebvallo approval ushers in off-the-shelf T-cell immunotherapies …industry, and it’s reasonable to anticipate that it will take at least 5 years for that patient impact to start to expand,” said Foster. Getting advanced therapies to European patients… December 20, 2022 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 15 Mar 2017 France Closes in on an HIV Cure by Detecting Cells with Dormant Viruses …latent viruses seem to be the main obstacle to completely eliminating the virus. The current standard of care, antiretroviral therapy (ART), only kills those cells in which the virus is… March 15, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 9 Dec 2024 CAR-T cell therapy for lupus: An emerging field with great potential …its treatment of hematological cancers just how effective this type of therapy can be. Table of contents How can CAR-T therapy treat lupus? We know that in oncology CAR-T therapy… December 9, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 19 Jul 2018 Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy …advantage of gamma delta T cells is that they can recognize their target independently of the type of molecule that presents it. “Therefore it reacts much quicker than alpha beta… July 19, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 11 Nov 2022 PACT Pharma reports data from CRISPR cancer study …of these T cells to mount a complete and effective attack on their cancer. PACT Pharma has developed technology platforms capable of creating engineered tumor-specific TCR-T cell therapies with the… November 11, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email